For example, CCNA1/cyclin A1 has recently been suggested as a potential diagnostic marker in papillary thyroid carcinoma and is a chemoresistance-associated biomarker in ovarian cancer (44, 45). This evidence concerns the gene CCNA1 and ovarian cancer.